Effect of highly active antiretroviral therapy on the incidence of HIV- associated malignancies at an Urban Medical Center

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 4 SUPPL., 1999, Pages

  Sparano, Joseph A ^a   Anand, Kanchana ^a   Desai, Jigna ^a   Mitnick, Robin J ^a   Kalkut, Gary E ^a   Hanau, Lawrence H ^a  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

AIDS; Cancer; HIV infection; Kaposi's sarcoma; Non Hodgkin's lymphoma

Indexed keywords

ANTIVIRUS AGENT;

AIDS RELATED COMPLEX; CANCER INCIDENCE; CONFERENCE PAPER; DISEASE ASSOCIATION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; URBAN POPULATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BIOPSY; CENTRAL NERVOUS SYSTEM NEOPLASMS; HOSPITALS, URBAN; HUMANS; INCIDENCE; INPATIENTS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; NEOPLASMS; OUTPATIENTS; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0033178773     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1. J Natl Cancer Inst 1994;86(22):1711-6.
2. Lyter DW, Bryant J, Thackeray R, Rinaldo CR, Kingsley LA. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 1998;13:2540-6.
3. Flexner C. HIV-protease Inhibitors. NEngl J Med 1998;338:1281-92.
4. Update: trends in AIDS incidence, deaths, and prevalence United States, 1996. MMWR Morb Mortal Wkly Rep 1997;46:165-73.
5. Update: trends in AIDS incidence United States, 1996. MMWR 1997;46(No. 37):861-7.
6. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
7. Torres RA, Barr M. Impact of combination therapy for HIV infection on inpatient census (letter). N Engl J Med 1997;336: 1531-2.
8. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, mid-year edition. Washington DC: U.S. Government Printing Office, 1996.
9. Sparano JA, Wiernik PH, Strack M, Leaf A, Becker N, Valentine ES. Infusional cyclophosphamide, doxorubicin, and etoposide in HIV- and HTLV-I-related non-Hodgkin's lymphoma: a highly active regimen. Blood 1993;81:2810-5.